Global Medical Foods Market

Medical Foods Market Size, Share, Growth Analysis, By Route of Administration(Oral and Enteral), By Product(Powder, Pills, Liquid, and Others), By Application(Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy-induced Diarrhea, Pathogen-related Infections), By Sales Channel(Online Sales, Institutional Sales, and Retail Sales), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35I2345 | Region: Global | Published Date: October, 2024
Pages: 165 | Tables: 120 | Figures: 71

Medical Foods Market Competitive Landscape

The medical foods market is intensely competitive, with businesses constantly engaging in strategic moves, like mergers, acquisitions, and new product launches. It helps them to increase their position in the market. Furthermore, many smaller businesses and startups are also entering the market, offering innovative medical nutrition solutions that can fulfil the requirements of specific medical conditions. The market's competitive nature is boosted by the increasing demand for personalized nutritional interventions. This requires constant research and development initiatives to stay ahead in this ever-changing business setting.

Top Player’s Company Profile

  • Danone S.A. (France)
  • Nestlé (Switzerland)
  • Abbott (U.S.)
  • Primus Pharmaceuticals, Inc. (U.S.)
  • Mead Johnson & Company, LLC. (U.S.)
  • Medtrition, Inc. (U.S.)
  • Fresenius Kabi AG (Germany)
  • Meiji Holdings Co., Ltd. (Japan)
  • Reckitt Benckiser Group PLC (U.K.)
  • Cerecin Inc. (U.S.)
  • Metagenics (U.S.)
  • ENTERA HEALTHCARE (U.S.)
  • Bausch Health Companies Inc. (Canada)
  • Upsher-Smith Laboratories, LLC (U.S.)

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Medical Foods Market size was valued at USD 22.45 Billion in 2022 and is poised to grow from USD 23.6 Billion in 2023 to USD 35.13 Billion by 2031, growing at a CAGR of 5.1 % in the forecast period (2024-2031).

The medical foods market is intensely competitive, with businesses constantly engaging in strategic moves, like mergers, acquisitions, and new product launches. It helps them to increase their position in the market. Furthermore, many smaller businesses and startups are also entering the market, offering innovative medical nutrition solutions that can fulfil the requirements of specific medical conditions. The market's competitive nature is boosted by the increasing demand for personalized nutritional interventions. This requires constant research and development initiatives to stay ahead in this ever-changing business setting. 'Danone S.A. (France)', 'Nestlé (Switzerland)', 'Abbott (U.S.)', 'Primus Pharmaceuticals, Inc. (U.S.)', 'Mead Johnson & Company, LLC. (U.S.)', 'Medtrition, Inc. (U.S.)', 'Fresenius Kabi AG (Germany)', 'Meiji Holdings Co., Ltd. (Japan)', 'Reckitt Benckiser Group PLC (U.K.)', 'Cerecin Inc. (U.S.)', 'Metagenics (U.S.)', 'ENTERA HEALTHCARE (U.S.)', 'Bausch Health Companies Inc. (Canada)', 'Upsher-Smith Laboratories, LLC (U.S.)'

Chronic disorders like diabetes, cardiovascular disease and metabolic disorders are becoming more prevalent globally. This is increasing demand for dietary therapies like medical foods. These types of food products help patients with unique dietary requirements. It also manages symptoms, enhances health outcomes and brings improvement to the quality of life.

Increasing Emphasis on Chronic Disease Management: There is an increasing focus on integrating medicinal foods into a wide range of care methods for chronic illness management. Diseases like diabetes, Alzheimer, and gastrointestinal can be treated with medical foods targeting metabolic routes and nutritional deficits. This trend indicates a massive shift toward preventative healthcare and integrated treatment methods. It can successfully combine medical and nutritional therapy.

North America is dominating the medical foods market with maximum market share. This region is witnessing a rapid growth in the market due to the increasing geriatric population suffering from chronic diseases. In recent times, a huge group of people have shown their reliance on medical foods. Furthermore, there has also been as increase in the number of infants and this age group is mostly dependent on powdered medical foods or liquid medical foods, boosting the demand of medical foods. It is expected that there will be a substantial growth in the infant population in the coming years. Nutritional deficiencies have also become a massive problem in this region and many patients with chronic diseases are suffering from nutritional defects. This is positively impacting the growth of the medical foods market. Medical professionals are also suggesting people suffering from neural problems or having neuro surgeries to consume medical foods, leading to the expansion of the market. These factors are contributing to the growth of the medical foods market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Medical Foods Market

Report ID: SQMIG35I2345

$5,300
BUY NOW GET FREE SAMPLE